Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Chia-Chi Chang

Chia-Chi Chang

Department of Nursing, National Yang Ming University, Taipei City, Taiwan

Title: The mediating role of health promotion lifestyles in the relationship between depressive symptoms and quality of life: A cross-sectional correlation study

Biography

Biography: Chia-Chi Chang

Abstract

About 27-30% of patients with chronic schizophrenia have depressive symptoms, and depressive symptoms reduce quality of life, but increase the risk of committing suicide. Objective: To examine the relationship among deprssive symptoms, health promotion lifestyles and quality of life in patients with chronic schizophrenia. Method: This study recruited patients diagnosed with schizophrenia who were admitted to a psychiatric inpatient rehabilitation wards and day care center in northern Taiwan. A total of 273 patients with chronic schizophrenia participated in this cross-sectional correlation study. A structural questionnaire was used to collect data, and which included demographric characteristics, Beck Depression Inventory II (BDI-II), Health-Promoting Lifestyles Profile (HPLP) and The World Health Organization Quality of Life BREF (WHOQOL-BREF). Hierarchical multiple regreesion was employed to analyse the mediating effects. Results: The 6 subscales of HPLP and four domains of WHOQOL-BREF presented positive correlations, but only self-actualization subscale of HPLP, depressive symptoms and QOL had negative correlation. As to the mediating role of HPLP between depressive symptoms and fours domains of QOL, self-actualization had fully mediation on environmental domain. The other three domains (physical health, psychological health, social relationship) had partial mediations. Conclusion Self- actualization can reduce the negative impact of depressive symptoms on their QOL in patients with chronic schizophrenia.